IRONWOOD PHARMACEUTICALS INC Quarterly Share-based Payment Arrangement, Expense in USD from Q1 2011 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Ironwood Pharmaceuticals Inc quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q1 2011 to Q2 2024.
  • Ironwood Pharmaceuticals Inc Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $8.57M, a 76.1% decline year-over-year.
  • Ironwood Pharmaceuticals Inc Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2024 was $33.6M, a 41.4% decline year-over-year.
  • Ironwood Pharmaceuticals Inc annual Share-based Payment Arrangement, Expense for 2023 was $59.6M, a 120% increase from 2022.
  • Ironwood Pharmaceuticals Inc annual Share-based Payment Arrangement, Expense for 2022 was $27M, a 21.4% increase from 2021.
  • Ironwood Pharmaceuticals Inc annual Share-based Payment Arrangement, Expense for 2021 was $22.3M, a 28.5% decline from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $33.6M $8.57M -$27.2M -76.1% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $60.8M $8.39M +$1.25M +17.6% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $59.6M $8.7M +$1.41M +19.4% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-16
Q3 2023 $58.1M $7.91M +$839K +11.9% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $57.3M $35.8M +$29.2M +443% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 $28.1M $7.13M +$1.04M +17.1% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 $27M $7.29M +$1.2M +19.7% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-16
Q3 2022 $25.8M $7.07M +$861K +13.9% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $25M $6.6M +$2.01M +43.8% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 $23M $6.09M +$693K +12.8% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 $22.3M $6.09M -$3.92M -39.1% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-16
Q3 2021 $26.2M $6.21M -$1.51M -19.5% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 $27.7M $4.59M -$2.5M -35.3% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 $30.2M $5.4M -$968K -15.2% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q4 2020 $31.2M $10M +$4.52M +82.4% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-16
Q3 2020 $26.7M $7.71M +$2.19M +39.7% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 $24.5M $7.09M +$754K +11.9% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 $23.7M $6.36M -$7.57M -54.3% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q4 2019 $31.3M $5.49M -$4.6M -45.6% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-18
Q3 2019 $35.9M $5.52M -$6.65M -54.6% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 $42.5M $6.34M -$3.45M -35.2% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-06
Q1 2019 $46M $13.9M +$4.89M +54.1% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-06
Q4 2018 $41.1M $10.1M +$4.3M +74.3% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-17
Q3 2018 $36.8M $12.2M +$3.47M +39.9% Jul 1, 2018 Sep 30, 2018 10-Q 2019-10-31
Q2 2018 $33.3M $9.78M +$643K +7.04% Apr 1, 2018 Jun 30, 2018 10-Q 2019-07-30
Q1 2018 $32.7M $9.04M +$1.76M +24.2% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-02
Q4 2017 $30.9M $5.79M -$1.59M -21.6% Oct 1, 2017 Dec 31, 2017 10-K 2020-02-13
Q3 2017 $32.5M $8.7M +$1.76M +25.4% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-06
Q2 2017 $30.7M $9.14M +$1.04M +12.9% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-06
Q1 2017 $29.7M $7.28M +$473K +6.95% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-04
Q4 2016 $29.2M $7.38M +$883K +13.6% Oct 1, 2016 Dec 31, 2016 10-K 2019-02-25
Q3 2016 $28.3M $6.93M +$293K +4.41% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-02
Q2 2016 $28M $8.1M +$1.19M +17.3% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-03
Q1 2016 $26.8M $6.81M +$1.38M +25.4% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-08
Q4 2015 $25.5M $6.5M -$2.06M -24.1% Oct 1, 2015 Dec 31, 2015 10-K 2018-02-22
Q3 2015 $27.5M $6.64M +$1.1M +19.9% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-07
Q2 2015 $26.4M $6.9M +$891K +14.8% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-08
Q1 2015 $25.5M $5.43M -$648K -10.7% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-10
Q4 2014 $26.2M $8.56M +$4.02M +88.7% Oct 1, 2014 Dec 31, 2014 10-K 2017-02-22
Q3 2014 $22.2M $5.54M +$337K +6.48% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-05
Q2 2014 $21.8M $6.01M +$1.2M +24.8% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-07
Q1 2014 $20.6M $6.07M +$799K +15.1% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-06
Q4 2013 $19.8M $4.54M -$123K -2.64% Oct 1, 2013 Dec 31, 2013 10-K 2016-02-19
Q3 2013 $20M $5.2M +$64K +1.25% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-05
Q2 2013 $19.9M $4.82M +$761K +18.8% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-05
Q1 2013 $19.1M $5.28M +$1.55M +41.8% Jan 1, 2013 Mar 31, 2013 10-Q 2014-04-29
Q4 2012 $17.6M $4.66M +$1.44M +44.7% Oct 1, 2012 Dec 31, 2012 10-K 2015-02-18
Q3 2012 $16.1M $5.14M +$2.27M +79.4% Jul 1, 2012 Sep 30, 2012 10-Q 2013-10-28
Q2 2012 $13.9M $4.06M +$1.11M +37.4% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-08
Q1 2012 $12.8M $3.72M +$1.02M +37.9% Jan 1, 2012 Mar 31, 2012 10-Q 2013-04-23
Q4 2011 $11.7M $3.22M Oct 1, 2011 Dec 31, 2011 10-K 2014-02-07
Q3 2011 $2.86M Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-06
Q2 2011 $2.95M Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-07
Q1 2011 $2.7M Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.